Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer

B. L. Gause, M. Sznol, W. C. Kopp, J. E. Janik, II W. Smith, R. G. Steis, W. J. Urba, W. Sharfman, R. G. Fenton, S. P. Creekmore, J. Holmlund, K. C. Conlon, L. A. VanderMolen, D. L. Longo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences